Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Simon Anderhub
Introduction
Simon Anderhub, a notable inventor based in Basel, Switzerland, has made significant strides in the field of pharmaceuticals through his innovative work. His expertise and research have culminated in the development of a patented compound that addresses critical medical needs.
Latest Patents
Simon Anderhub holds a patent for "Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase." This invention represents a breakthrough in modulating indoleamine 2,3-dioxygenase (IDO1), which is associated with various diseases. The invention specifically offers compounds that can be used in the prophylaxis and treatment of IDO1-mediated diseases, including enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.
Career Highlights
Simon currently works at Phenex Discovery Verwaltungs GmbH, where he collaborates with a team of experts dedicated to advancing drug discovery and development. His efforts in research have established him as a prominent figure in the field of medicinal chemistry and pharmaceutical innovations.
Collaborations
Throughout his career, Simon has had the opportunity to work alongside esteemed colleagues such as Christoph Steeneck and Olaf Kinzel. Their collaborative efforts have further propelled the advancements in their respective research areas, fostering an innovative environment focused on discovering potent therapeutic agents.
Conclusion
With his patent and ongoing work at Phenex Discovery Verwaltungs GmbH, Simon Anderhub exemplifies the essence of innovation in pharmaceuticals. His contributions to the modulation of IDO1 through his invention are noteworthy and illustrate the impact inventors can have on medical science and treatment options. Simon's journey is a testament to the importance of creativity and research in addressing global health challenges.